Skip to main content

22-431 Offer Patients Added Treatment Options for COVID-19 with Oral Antivirals

June 10, 2022

This information applies to Physicians and Independent Practice Associations.

PaxlovidTM and LagevrioTM – authorized for emergency use by the U.S. Food and Drug Administration – can be prescribed to treat mild to moderate COVID-19 for use at home.

This flyer shares information about two COVID-19 oral antiviral medications – PaxlovidTM and LagevrioTM. These are available by prescription only to individuals who qualify, have mild to moderate COVID-19 symptoms and who are at high risk.

Download the provider updateThis PDF document will open in a new window.

Contact Us icon

Need help? We're here for you.

Contact Us
Y0020_WCM_87476E Last Updated On: 2/9/2024
On April 22, 2024, UnitedHealth Group issued a press release, providing an update on the Change Healthcare cybersecurity incident that occurred on Feb. 21, 2024. Given the size of the data impacted, the investigation to determine whose data is impacted is expected to take several months. UnitedHealth Group believes this situation will impact “a substantial proportion of people in America” and is offering immediate credit monitoring and identity protection services, as well as a dedicated contact center to address questions. Visit Change Healthcare Cyberattack Support and/or reach out to the contact center at 1-866-262-5342 regarding any questions.